These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26892556)

  • 1. An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.
    Kong L; Vijayakrishnan B; Kowarik M; Park J; Zakharova AN; Neiwert L; Faridmoayer A; Davis BG
    Nat Chem; 2016 Mar; 8(3):242-9. PubMed ID: 26892556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis.
    Reinhardt A; Yang Y; Claus H; Pereira CL; Cox AD; Vogel U; Anish C; Seeberger PH
    Chem Biol; 2015 Jan; 22(1):38-49. PubMed ID: 25601073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in the Design and Use of Synthetic "Internal Glycan" Vaccines.
    Lakshminarayanan A; Vijayakrishnan B; Bayley H; Davis BG
    Methods Enzymol; 2017; 597():335-357. PubMed ID: 28935110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.
    Kahler CM; Datta A; Tzeng YL; Carlson RW; Stephens DS
    Glycobiology; 2005 Apr; 15(4):409-19. PubMed ID: 15574803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.
    Baraldo K; Mori E; Bartoloni A; Norelli F; Grandi G; Rappuoli R; Finco O; Del Giudice G
    Infect Immun; 2005 Sep; 73(9):5835-41. PubMed ID: 16113302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-aminoacylation of bacterial glycoconjugates: from native structure to vaccine design.
    Gamian A; Mieszała M; Lipiński T; Zielińska-Kuźniarz K; Gawlik-Jędrysiak M; Dzierzba K; Pietkiewicz J; Szeja W
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1781-91. PubMed ID: 21902628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.
    St Michael F; Cairns CM; Filion AL; Biolchi A; Brunelli B; Giuliani M; Richards JC; Cox AD
    Glycoconj J; 2014 Jan; 31(1):25-39. PubMed ID: 24013955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
    Khatun F; Stephenson RJ; Toth I
    Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
    van der Ley P; Steeghs L; Hamstra HJ; ten Hove J; Zomer B; van Alphen L
    Infect Immun; 2001 Oct; 69(10):5981-90. PubMed ID: 11553534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
    Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
    J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in lipopolysaccharide-based glycoconjugate vaccines.
    Zhu H; Rollier CS; Pollard AJ
    Expert Rev Vaccines; 2021 Dec; 20(12):1515-1538. PubMed ID: 34550840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterials: A sweet vaccine.
    Bundle D
    Nat Chem; 2016 Mar; 8(3):201-2. PubMed ID: 26892546
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
    Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
    Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing a new antifungal glycoconjugate vaccine.
    Johnson MA; Bundle DR
    Chem Soc Rev; 2013 May; 42(10):4327-44. PubMed ID: 23232662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Nucleotide Polymorphisms Found in the migA and wbpX Glycosyltransferase Genes Account for the Intrinsic Lipopolysaccharide Defects Exhibited by Pseudomonas aeruginosa PA14.
    Hao Y; Murphy K; Lo RY; Khursigara CM; Lam JS
    J Bacteriol; 2015 Sep; 197(17):2780-91. PubMed ID: 26078447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
    Wright JC; Hood DW; Randle GA; Makepeace K; Cox AD; Li J; Chalmers R; Richards JC; Moxon ER
    J Bacteriol; 2004 Oct; 186(20):6970-82. PubMed ID: 15466050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7.
    Rivera M; Chivers TR; Lam JS; McGroarty EJ
    J Bacteriol; 1992 Apr; 174(7):2407-11. PubMed ID: 1551858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.
    Liao G; Zhou Z; Guo Z
    Chem Commun (Camb); 2015 Jun; 51(47):9647-50. PubMed ID: 25973942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of LptH, the periplasmic component of the lipopolysaccharide transport machinery from Pseudomonas aeruginosa.
    Bollati M; Villa R; Gourlay LJ; Benedet M; Dehò G; Polissi A; Barbiroli A; Martorana AM; Sperandeo P; Bolognesi M; Nardini M
    FEBS J; 2015 May; 282(10):1980-97. PubMed ID: 25735820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.